The Importance of Antiviral Prophylaxis against Hepatitis B Virus in Patients under Immunosuppressive Therapy

---

AKSOY F., KAYA S., Karakoc H. N., YILMAZ G., Atalar S., Koksal I.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.25, sa.2, ss.50-54, 2019 (ESCI, TRDizin)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 25 Sayı: 2
• Basım Tarihi: 2019
• Doi Numarası: 10.4274/vhd.galenos.2019.2018.0027
• Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.50-54
• Karadeniz Teknik Üniversitesi Adresli: Evet

Özet

Objectives: Immunosuppressive (IS) therapies present a risk of reactivation in patients with previous or known hepatitis B virus (HBV) infection and may cause mortality and morbidity. Before starting these therapies, patients should be tested for HBV serology and evaluated for antiviral therapy.